NM_000394.4:c.166G>A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM1BP4_Moderate
The NM_000394.4(CRYAA):c.166G>A(p.Val56Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000394.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 1AN: 75948Hom.: 0 Cov.: 9 FAILED QC
GnomAD3 exomes AF: 0.0000201 AC: 5AN: 248248Hom.: 0 AF XY: 0.0000223 AC XY: 3AN XY: 134452
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000127 AC: 9AN: 707586Hom.: 1 Cov.: 9 AF XY: 0.0000218 AC XY: 8AN XY: 367470
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000132 AC: 1AN: 75948Hom.: 0 Cov.: 9 AF XY: 0.0000274 AC XY: 1AN XY: 36510
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.166G>A (p.V56M) alteration is located in exon 1 (coding exon 1) of the CRYAA gene. This alteration results from a G to A substitution at nucleotide position 166, causing the valine (V) at amino acid position 56 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Cataract 9 multiple types Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at